Carregant...
Myasthenia Gravis Induced by Ipilimumab in a Patient With Metastatic Melanoma
In daily clinical practice, there is a growing number of patients receiving new biological agents used in the treatment of malignancies. Ipilimumab is a fully humanized monoclonal antibody approved for patients with melanoma. It acts as an immune checkpoint inhibitor, binding and blocking cytotoxic...
Guardat en:
| Publicat a: | Front Neurol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5891586/ https://ncbi.nlm.nih.gov/pubmed/29666602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00150 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|